HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹11 Cr | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HALEOS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of HALEOS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | -10.84 | |
| Mar2024 | ₹12 Cr | -5.62 | |
| Mar2023 | ₹13 Cr | 19.44 | |
| Mar2022 | ₹11 Cr | -1.32 | |
| Mar2021 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹457.5 Cr | -4.3% | 8.9% | 19.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | -4.3% |
8.9% |
19.1% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses